Asian securitisation market hits post-crisis record

Total issuance increased by 67% compared with the previous year, largely due to increased activity in South Korea, the rating agency said in its annual report on Asian securitisation. Overall, Korea accounted for seven of the 10 cross-border deals, or 84% of total issuance.

Korean consumer finance receivables topped the asset classes, comprising 54% of the total volumes in Asia. Most recently, Korean credit card issuer, LG Card, issued the first international securitisation of credit card receivables in December, totalling $475 million.

The renewed interest of monoline insurers in Asia’s securitisation market also played a part in the growth, Moody’s said. Monoline insurers provided financial guarantees on 65% of the total cross-border debt – all from Korea.

Looking ahead, Moody’s said it expects the market to continue its growth trend, estimating $3 billion of cross-border issuance, the bulk of which again is expected out of Korea. But the report also pointed to the synthetic collateralised debt obligation (CDO) market as a potential growth area in Singapore, due to increased bank merger activity and regulatory liberalisation. The Development Bank of Singapore (DBS) launched the first Asia ex-Japan balance sheet synthetic collateralised loan obligation (CLO) late last year, totalling S$224 million ($122 million) in tranched notes (see RiskNews November 27).

The report also points to increased activity in Malaysia and Taiwan in the coming year. Malaysia published guidelines for asset-backed securities (ABS) last April, while Taiwan is awaiting the ratification of ABS legislation, expected early this year.

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact or view our subscription options here:

You are currently unable to copy this content. Please contact to find out more.

You need to sign in to use this feature. If you don’t have a account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here